What is Gemfibrozil classified as?

Gemfibrozil is classified as an antihyperlipidemic agent, specifically a fibrate. Its primary function is to lower lipid levels in the blood, particularly by decreasing triglyceride levels and increasing high-density lipoprotein (HDL) cholesterol. Gemfibrozil activates peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which plays a key role in the regulation of fatty acid metabolism.

As an antihyperlipidemic, gemfibrozil is often used in conjunction with dietary changes and exercise to manage lipid disorders, especially in patients with high triglyceride levels or those at risk for pancreatitis due to elevated triglycerides. Understanding the classification of gemfibrozil helps in recognizing its therapeutic use and mechanism of action within the context of managing dyslipidemia.